*ST雅博(002323.SZ):子公司中標3735.48萬元鄭州南站ZNZFS-1標段項目三標段金屬屋面工程
格隆匯 12 月 22日丨*ST雅博(002323.SZ)公佈,公司全資子公司山東雅百特科技有限公司(“山東雅百特”)於近日收到中鐵建工集團有限公司深圳分公司送達的《中標通知書》,確認山東雅百特為鄭州南站ZNZFS-1標段項目三標段金屬屋面工程的中標人。
鄭州南站的建設運營將擴充航空港區腹地範圍和口岸通關能力,對促進航空港區現代物流業發展具有重要的意義。目前山東雅百特中標金額為約3735.48萬元,佔公司2019年度經審計營業收入的35.69%。項目順利實施後,預計對公司未來經營業績產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.